This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Jun 1;20(11):2756; author reply 2756-7.

doi: 10.1200/JCO.2002.20.11.2756.

Critical factors in optimizing graft-versus-leukemia effect for relapsed leukemias

Suparno Chakrabarti

PMID: 12039941
DOI: 10.1200/JCO.2002.20.11.2756

Comment

Critical factors in optimizing graft-versus-leukemia effect for relapsed leukemias

Suparno Chakrabarti. J Clin Oncol. 2002.

. 2002 Jun 1;20(11):2756; author reply 2756-7.

doi: 10.1200/JCO.2002.20.11.2756.

Author

Suparno Chakrabarti

PMID: 12039941
DOI: 10.1200/JCO.2002.20.11.2756

No abstract available

PubMed Disclaimer

Comment on

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.
Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr. Levine JE, et al. J Clin Oncol. 2002 Jan 15;20(2):405-12. doi: 10.1200/JCO.2002.20.2.405. J Clin Oncol. 2002. PMID: 11786567 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information